High-density lipoprotein cholesterol and systemic arterial hypertension are associated with hepatic necroinflammatory activity in patients with chronic hepatitis c

dc.creatorGustavo Henrique de Puy Esouza
dc.creatorLuciana Diniz Silva
dc.creatorDiego Alves Vieira
dc.creatorGifone Aguiar Rocha
dc.creatorAgnaldo Soares Lima
dc.creatorPaula Vieira Teixeira Vidigal
dc.date.accessioned2025-06-03T19:38:40Z
dc.date.accessioned2025-09-08T23:57:53Z
dc.date.available2025-06-03T19:38:40Z
dc.date.issued2023
dc.format.mimetypepdf
dc.identifier.doi10.1590/s0004-2803.230302023-03
dc.identifier.issn16784219
dc.identifier.urihttps://hdl.handle.net/1843/82755
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.rightsAcesso Aberto
dc.subjectHepacivirus
dc.subjectHepatitis C, Chronic
dc.subjectDiabetes Mellitus
dc.subjectHypertension
dc.subjectCholesterol, HDL
dc.subject.otherHepatitis C virus
dc.subject.otherchronic hepatitis C
dc.subject.otherDiabetes Mellitus
dc.subject.otherHypertension
dc.subject.otherHDL-Colesterol
dc.subject.otherLiver histology
dc.titleHigh-density lipoprotein cholesterol and systemic arterial hypertension are associated with hepatic necroinflammatory activity in patients with chronic hepatitis c
dc.typeArtigo de periódico
local.citation.epage299
local.citation.issue3
local.citation.spage287
local.citation.volume60
local.description.resumoABSTRACT – Background – Approximately 71 million people are chronically infected with hepatitis C virus (HCV) worldwide. A significant number of these individuals will develop liver cirrhosis and/or hepatocellular carcinoma. Beyond the liver, there is a sizeable body of scientific evidence linking cardiovascular disease and chronic hepatitis C (CHC); however, the biological mechanisms behind the concurrence of these conditions have not been completely clarified yet. Objective – To evaluate associations between hepatic histology, clinical comorbidities and lipid profile in patients with CHC. To investigate associations between liver histology and demographic, nutritional, biochemical and virological parameters. Methods – Eight-five patients with CHC prospectively underwent hepatic biopsy. Liver fragments were obtained from each patient by percutaneous route using a Menghini needle. Fibrosis was evaluated according to the METAVIR scoring system, as follows: F0, no fibrosis; F1, fibrous portal expansion; F2, fibrous portal widening with few septa; F3, bridging fibrosis with architectural distortion; and F4, liver cirrhosis. The activity was classified based on the degree of lymphocyte infiltration and hepatocyte necrosis, from A0 to A3. The diagnosis of liver disease was based on clinical, biochemical, histological, and radiological methods. The data were analyzed by logistic regression models. Results – This cross-sectional study included 85 outpatients followed at the tertiary care ambulatory centre with a mean age of 57.2±10.7 years and 45 (52.9%) were females. There were 10 patients with cirrhosis. Patients with a METAVIR F3-F4 were significantly older (P=0.02) and had higher levels of ALT (P=0.0006), AST (P<0.0001), γ-GT (P=0.03) and bilirubin (P=0.001) and higher prothrombin time than patients with F0-F2 score. Albumin levels (P=0.01) were significantly lower in METAVIR F3-F4. Age (OR=1.09; 95%CI=1.02–1.16; P=0.02), steatosis (OR=4.03; 95%CI=1.05–15.45; P=0.04) and high-density lipoprotein cholesterol (HDL-C) <60 mg/dL (OR=7.67; 95%CI=1.71–34.49; P=0.008) were independently associated with fibrosis. Hypertension (OR=6.36; 95%CI=1.31–30.85; P=0.02) and HDL-C <60 mg/dL (OR=9.85; 95%CI=2.35–41.39; P=0.002) were independently associated with necroinflammatory activity. Hypertension (OR=6.94; 95%CI=1.92–25.05; P=0.003) and HDL-C <60 mg/dL (OR=3.94; 95%CI=1.27–12.3; P=0.02) were associated with interface inflammatory activity. Triglycerides (TG ≥150 mg/dL) remained associated with lobular inflammatory activity. Conclusion – HDL cholesterol levels <60 mg/dL were independently associated with necroinflammatory activity in chronic hepatitis C. Patients with hypertension are at an increased risk of developing necroinflammatory activity.
local.publisher.countryBrasil
local.publisher.departmentMED - DEPARTAMENTO DE ANATOMIA PATOLÓGICA E MEDICINA LEGAL
local.publisher.departmentMED - DEPARTAMENTO DE PROPEDÊUTICA COMPLEMENTAR
local.publisher.initialsUFMG
local.url.externahttps://doi.org/10.1590/S0004-2803.230302023-03

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
High-density lipoprotein pdfa.pdf
Tamanho:
186.91 KB
Formato:
Adobe Portable Document Format

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição: